Vanguard Group Inc Akero Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,704,411 shares of AKRO stock, worth $161 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,704,411

Previous 3,676,581 0.76%

Holding current value

$161 Million

Previous $105 Million 2.3%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$26.75 - $35.28 $744,452 - $981,842	27,830 Added 0.76%	3,704,411 $103 Million
Q3 2024 Nov 13, 2024	SELL	$21.45 - $29.34 $611,518 - $836,454	-28,509 Reduced 0.77%	3,676,581 $105 Million
Q2 2024 Aug 13, 2024	BUY	$18.31 - $24.62 $643,907 - $865,811	35,167 Added 0.96%	3,705,090 $86.9 Million
Q1 2024 May 10, 2024	BUY	$17.76 - $31.18 $10.4 Million - $18.2 Million	584,875 Added 18.96%	3,669,923 $92.7 Million
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $829,215 - $3.67 Million	72,866 Added 2.42%	3,085,048 $72 Million
Q3 2023 Nov 14, 2023	BUY	$41.19 - $52.25 $13.4 Million - $17 Million	326,308 Added 12.15%	3,012,182 $152 Million
Q2 2023 Aug 14, 2023	BUY	$36.89 - $56.88 $20.2 Million - $31.1 Million	546,981 Added 25.57%	2,685,874 $125 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $50.24 $831,940 - $1.12 Million	22,322 Added 1.05%	2,138,893 $81.8 Million
Q4 2022 Feb 10, 2023	BUY	$33.44 - $54.8 $12.6 Million - $20.6 Million	375,978 Added 21.6%	2,116,571 $116 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $4.36 Million - $14.6 Million	429,579 Added 32.77%	1,740,593 $59.3 Million
Q2 2022 Aug 12, 2022	BUY	$8.0 - $15.01 $672,824 - $1.26 Million	84,103 Added 6.85%	1,311,014 $12.4 Million
Q1 2022 May 13, 2022	BUY	$12.97 - $22.26 $732,701 - $1.26 Million	56,492 Added 4.83%	1,226,911 $17.4 Million
Q4 2021 Feb 14, 2022	BUY	$19.87 - $26.24 $1.79 Million - $2.36 Million	89,834 Added 8.31%	1,170,419 $24.8 Million
Q3 2021 Nov 12, 2021	BUY	$18.65 - $25.46 $390,698 - $533,361	20,949 Added 1.98%	1,080,585 $24.2 Million
Q2 2021 Aug 13, 2021	BUY	$24.81 - $32.35 $26.3 Million - $34.3 Million	1,059,636 New	1,059,636 $26.3 Million

Others Institutions Holding AKRO

# of Institutions

209

Shares Held

66.9M

Call Options Held

321K

Put Options Held

558K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $2.02B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Akero Therapeutics, Inc. Transaction History